Morningstar

Seragon Publishes Data for Longevity Drug SRN-901 Showing Significant Lifespan and Healthspan Extension

IRVINE, Calif., April 15, 2026 /PRNewswire/ -- Seragon Biosciences Inc. today announced the publication of comprehensive preclinical study results in the peer-reviewed journal Drug Design, Development ...
USA Today

Sports Replay Now Bringing Professional Level Film Room & Analytics to Every Dedicated Coach, Player, League, and Team in America

SRN Launches to Disrupt Youth Athletics with Affordable, Next-Generation Film Room That Levels the Playing Field for the $45 Billion Youth Sports Industry – at $159.99 a Year LOS ANGELES, CA / ACCESS ...
Business Insider

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma

SAN FRANCISCO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...
Brattleboro Reformer

SRN Advisors, LLC Announces Changes to Investment Objective, Principal Investment Strategies and Name for the Siren Nasdaq NexGen Economy ETF (BLCN)

Don't miss the big stories. Like us on Facebook. HUNTINGDON VALLEY, Pa., Dec. 19, 2025 /PRNewswire/ -- SRN Advisors, LLC (SRN) announced today that, effective as of December 29, 2025 (the "Effective ...